Elizabeth A Garofalo

Title: Innovations by Elizabeth A Garofalo

Introduction

Elizabeth A Garofalo is a notable inventor based in Marcellus, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin antibiotics. With a total of 2 patents, her work has had a meaningful impact on antibiotic preparation processes.

Latest Patents

Her latest patents include a process for the preparation of a cephalosporin antibiotic. This invention provides an anhydrous acylation process for the preparation of antibiotic, cefepime dihydrochloride hydrate, which is substantially free of the anti-isomer and the .DELTA..sup.2 isomer. The process involves the N-acylation of a silylated derivative of 7-amino-3-[(1-methyl-1-pyrrolidinio)-methyl]ceph-3-em-4-carboxylate with the syn-isomer of 2-(2-aminothiazol-4-yl)-2-methoxyimino acetyl chloride hydrochloride. Another significant patent is related to a new crystalline dihydrochloride dihydrate salt of the cephalosporin antibiotic, cefepime. This invention provides a temperature and moisture stable crystalline dihydrochloride dihydrate form of cefepime, which has enhanced stability and a specific x-ray powder diffraction pattern.

Career Highlights

Elizabeth A Garofalo is currently associated with Bristol-Myers Squibb Company, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing antibiotic formulations and improving their stability and efficacy.

Collaborations

Throughout her career, she has collaborated with notable colleagues such as Gary M Lim and John M Roubie. These collaborations have further enriched her research and development efforts in the field of pharmaceuticals.

Conclusion

Elizabeth A Garofalo's contributions to antibiotic development exemplify her dedication to innovation in the pharmaceutical industry. Her patents reflect her expertise and commitment to improving healthcare solutions.